Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $35.85 USD
Change Today 0.00 / 0.00%
Volume 0.0
HKMPF On Other Exchanges
Symbol
Exchange
London
OTC US
OTC US
Frankfurt
As of 8:10 PM 03/3/15 All times are local (Market data is delayed by at least 15 minutes).

hikma pharmaceuticals plc (HKMPF) Snapshot

Open
$35.85
Previous Close
$35.85
Day High
$35.85
Day Low
$35.85
52 Week High
01/29/15 - $35.95
52 Week Low
09/26/14 - $26.53
Market Cap
7.1B
Average Volume 10 Days
0.0
EPS TTM
--
Shares Outstanding
198.6M
EX-Date
04/16/15
P/E TM
--
Dividend
$0.24
Dividend Yield
0.87%
Current Stock Chart for HIKMA PHARMACEUTICALS PLC (HKMPF)

Related News

No related news articles were found.

hikma pharmaceuticals plc (HKMPF) Related Businessweek News

View More BusinessWeek News

hikma pharmaceuticals plc (HKMPF) Details

Hikma Pharmaceuticals PLC develops, manufactures, and markets a range of generic and in-licensed pharmaceutical products in solid, semi-solid, liquid, and injectable final dosage forms in the Middle East and North Africa, the United States, and Europe. It operates through three segments: Branded, Injectable, and Generic. The Branded segment offers 499 products in 1,256 dosage strengths and forms, which lie in the anti-infective, cardiovascular, central nervous system (CNS), and diabetes therapeutic areas. The Injectables segment markets 200 branded and non-branded products in 379 dosage strengths and forms with a focus on CNS, anti-infective, musculoskeletal, cardiovascular, and oncological therapeutic areas. This segment also offers sterile liquid, powder, lyophilized, and cytotoxic products. The Generics segment provides 11 products in 44 dosage strengths and forms for various therapeutic areas including analgesic, anti-infective, anti-inflammatory, cardiovascular, CNS, respiratory, hormonal, and others. This segment markets its products to chain stores, wholesalers, distributors, health systems, and governmental agencies in the form of tablets, capsules, solutions, and suspensions. In addition, the company offers anesthetics, anti-histamines, gastroenterology and metabolism, dermatology, genitourinary system, transplantation, vitamins and supplements, and miscellaneous products. Further, it manufactures plastic specialized medicinal sterile containers and API; and conducts bio-equivalency studies. The company was founded in 1978 and is based in London, the United Kingdom.

hikma pharmaceuticals plc (HKMPF) Top Compensated Officers

Chairman and Chief Executive Officer
Total Annual Compensation: $2.4M
Executive Vice Chairman, Chief Executive Offi...
Total Annual Compensation: $1.6M
Compensation as of Fiscal Year 2013.

hikma pharmaceuticals plc (HKMPF) Key Developments

Hikma Pharmaceuticals plc(LSE:HIK) added to FTSE 100 Index

Hikma Pharmaceuticals plc(LSE:HIK) added to FTSE 100 Index

Hikma Pharmaceuticals plc(LSE:HIK) dropped from FTSE 250 (Ex Investment Companies) Index (GBP)

Hikma Pharmaceuticals plc(LSE:HIK) dropped from FTSE 250 (Ex Investment Companies) Index (GBP)

Hikma Pharmaceuticals plc(LSE:HIK) dropped from FTSE 250 Index

Hikma Pharmaceuticals plc(LSE:HIK) dropped from FTSE 250 Index

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
HKMPF:US $35.85 USD 0.00

HKMPF Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Akorn Inc $48.48 USD +2.21
BTG PLC 719.00 GBp -3.50
Richter Gedeon Nyrt 3,952 -68.00
Impax Laboratories Inc $45.74 USD +0.87
STADA Arzneimittel AG €30.85 EUR +0.52
View Industry Companies
 

Industry Analysis

HKMPF

Industry Average

Valuation HKMPF Industry Range
Price/Earnings 23.0x
Price/Sales 4.2x
Price/Book 5.3x
Price/Cash Flow 22.8x
TEV/Sales 4.3x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact HIKMA PHARMACEUTICALS PLC, please visit www.hikma.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.